Evidence map›Paper›PMID 26192182›Full record

ArticlePloS one2015

Prematurity and Low Birth Weight did not Correlate with Anti-Toxoplasma gondii Maternal Serum Profiles--a Brazilian Report.

Mariana Machado Lemos Fochi, Sabrina Baring, Lígia Cosentino Junqueira Franco Spegiorin, Denise Cristina Mós Vaz-Oliani, Eloisa Aparecida Galão, Antonio Hélio Oliani, Luiz Carlos de Mattos, Cinara Cássia Brandão de Mattos

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Adverse pregnancy outcomes in Toxoplasma gondii seropositive Hispanic women.The journal of obstetrics and gynaecology research · 2023
    Article
  4. The Impact of LatentMicroorganisms · 2022
    Article
  5. Pathogens (Basel, Switzerland) · 2022
    Article
  6. Article
  7. A pilot study on screening for gestational/congenital toxoplasmosis of pregnant women at delivery in the Eastern Province of Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  8. Evaluation ofAdvanced biomedical research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mariana Machado Lemos FochiImmunogenetics Laboratory, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil; FAMERP Toxoplasma Research Group, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil.
Sabrina BaringObstetrics and Gynecology Service, Hospital de Base, Fundação Faculdade Regional de Medicina de São José do Rio Preto-HB-FUNFARME, São José do Rio Preto, São Paulo, Brazil.
Lígia Cosentino Junqueira Franco SpegiorinObstetrics and Gynecology Service, Hospital de Base, Fundação Faculdade Regional de Medicina de São José do Rio Preto-HB-FUNFARME, São José do Rio Preto, São Paulo, Brazil; Department of Gynecology and Obstetrics, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil; Hospital da Criança e Maternidade de São José do Rio Preto-HCM, São José do Rio Preto, São Paulo, Brazil; FAMERP Toxoplasma Research Group, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil.
Denise Cristina Mós Vaz-OlianiObstetrics and Gynecology Service, Hospital de Base, Fundação Faculdade Regional de Medicina de São José do Rio Preto-HB-FUNFARME, São José do Rio Preto, São Paulo, Brazil; Department of Gynecology and Obstetrics, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil; Hospital da Criança e Maternidade de São José do Rio Preto-HCM, São José do Rio Preto, São Paulo, Brazil.
Eloisa Aparecida GalãoObstetrics and Gynecology Service, Hospital de Base, Fundação Faculdade Regional de Medicina de São José do Rio Preto-HB-FUNFARME, São José do Rio Preto, São Paulo, Brazil; Department of Gynecology and Obstetrics, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil; Hospital da Criança e Maternidade de São José do Rio Preto-HCM, São José do Rio Preto, São Paulo, Brazil.
Antonio Hélio OlianiDepartment of Gynecology and Obstetrics, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil; Hospital da Criança e Maternidade de São José do Rio Preto-HCM, São José do Rio Preto, São Paulo, Brazil.
Luiz Carlos de MattosImmunogenetics Laboratory, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil; FAMERP Toxoplasma Research Group, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil.
Cinara Cássia Brandão de MattosImmunogenetics Laboratory, Department of Molecular Biology, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil; FAMERP Toxoplasma Research Group, Faculdade de Medicina de São José do Rio Preto-FAMERP, São José do Rio Preto, São Paulo, Brazil.
Faculdade de Medicina de São José do Rio Preto · BRHospital de Base · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational Toxoplasma gondii infection is considered a major risk factor for miscarriage, prematurity and low birth weight in animals. However, studies focusing on this topic in humans are scarce. The objective of this study is to determine whether anti-Toxoplasma gondii maternal serum profiles correlate prematurity and low birth weight in humans. The study examined 213 pregnant women seen at the High-Risk Pregnancy Hospital de Base, São José do Rio Preto, São Paulo, Brazil. All serological profiles (IgM-/IgG+; IgM-/IgG-; IgM+/IgG+) were determined by ELISA commercial kits. Maternal age, gestational age and weight of the newborn at birth were collected and recorded in the Statement of Live Birth. Prematurity was defined as gestational age <37 weeks and low birth weight ≤ 2499 grams. The t-test was used to compare values (p < 0.05). The mean maternal age was 27.6±6.6 years. Overall, 56.3% (120/213) of the women studied were IgM-/IgG+, 36.2% (77/213) were IgM-/IgG- and 7.5% (16/213) were IgM+/IgG+. The average age of the women with serological profile IgM+/IgG+ (22.3±3.9 years) was different from women with the profile IgM-/IgG+ (27.9±6.7 years, p = 0.0011) and IgM-/IgG- (27.9±6.4 years, p = 0.0012). There was no statistically significant difference between the different serological profiles in relation to prematurity (p = 0.6742) and low birth weight (p = 0.7186). The results showed that prematurity and low birth weight did not correlate with anti-Toxoplasma gondii maternal serum profiles.

Indexed as

Abortion, SpontaneousAdultAntibodies, ProtozoanBrazilFemaleHumansInfant, Low Birth WeightInfant, NewbornInfant, PrematurePregnancyRisk FactorsToxoplasmaToxoplasmosisAntibodies, Protozoan

Identifiers

PMID26192182
PMCPMC4508015
OpenAlexW1611883559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.